Akebia Therapeutics Inc. sell BiotechBee
Start price
17.03.24
/
60%
€1.51
Target price
30.11.25
€0.30
Performance (%)
76.96%
End price
28.03.24
€2.67
Summary
This prediction ended on 28.03.24 with a price of €2.67. The SELL prediction by BiotechBee for Akebia Therapeutics Inc. was trending in the completely wrong direction and closed with a performance of 76.96%. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Akebia Therapeutics Inc. | 10.459% | 10.459% |
iShares Core DAX® | 3.178% | 0.980% |
iShares Nasdaq 100 | 2.972% | 0.925% |
iShares Nikkei 225® | 0.545% | -4.556% |
iShares S&P 500 | 2.367% | 0.833% |
According to BiotechBee what are the pros and cons of Akebia Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Sell mit Kursziel 0,3
In the thread Trading Akebia Therapeutics Inc.
Sell beendet